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ABSTRACT
Using libraries of replication origins generated
previously, we identified three clones that sup-
ported the autonomous replication of their respec-
tive plasmids in transformed, but not in normal cells.
Assessment of their in vivo replication activity by
in situ chromosomal DNA replication assays
revealed that the chromosomal loci corresponding
to these clones coincided with chromosomal repli-
cation origins in all cell lines, which were more
active by 2–3-fold in the transformed by comparison
to the normal cells. Evaluation of pre-replication
complex (pre-RC) protein abundance at these
origins in transformed and normal cells by
chromatin immunoprecipitation assays, using
anti-ORC2, -cdc6 and -cdt1 antibodies, showed
that they were bound by these pre-RC proteins in
all cell lines, but a 2–3-fold higher abundance was
observed in the transformed by comparison to
the normal cells. Electrophoretic mobility shift
assays (EMSAs) performed on the most efficiently
replicating clone, using nuclear extracts from the
transformed and normal cells, revealed the
presence of a DNA replication complex in trans-
formed cells, which was barely detectable in
normal cells. Subsequent supershift EMSAs sug-
gested the presence of transformation-specific
complexes. Mass spectrometric analysis of these
complexes revealed potential new protein players
involved in DNA replication that appear to correlate
with cellular transformation.
INTRODUCTION
According to the replicon model, origins of DNA replica-
tion are deﬁned by a speciﬁc DNA sequence, termed the
replicator, and an initiator protein that binds to the origin
(1). There is an estimated number of 10
4–10
6 replication
origins per mammalian cell (2,3), clusters of which are
activated at diﬀerent times in S-phase and are replicated
in a deﬁned spatial and temporal order (4). Control of
replication frequency and timing is exerted at the level
of initiation (5). For the faithful duplication of DNA
and a successful completion of one round of the cell
cycle, eukaryotic cells require precise orchestration of
the actions of replication proteins (6). Chromosomes
replicate their DNA in units called replicons, each con-
taining one functional origin of DNA replication (initia-
tion start site) (2). The average size of a replicon varies
from 10 to 300kb, depending on the stage of development,
growth conditions or cell transformation status (3,7,8). In
the early stages of embryonic development, when fast
growth occurs, the replicon size is much smaller than in
somatic cells and hence the number of initiation sites may
be as much as 10-fold greater (4,9). As cellular transfor-
mation and tumor progression are thought to resemble a
return to the early stages of embryonic development (9), a
comparative analysis of the activity of replication origins
between tumor and normal cells may give us insight into
the mechanisms that regulate the initiation of DNA rep-
lication in normal cells and how they may become
deregulated by the transformation process.
Cellular transformation has been shown to modify the
regulation of origin activation, resulting in diﬀerential
origin usage (10–13) as well as a decrease in the average
replicon size by approximately half (14,15). Furthermore,
transformed cells exhibit a 2–10-fold increase of
*To whom correspondence should be addressed. Tel: +1 (514) 398 3536; Fax: +1 (514) 398 6769; Email: maria.zannis@mcgill.ca
2314–2331 Nucleic Acids Research, 2010, Vol. 38, No. 7 Published online 11 January 2010
doi:10.1093/nar/gkp1192
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.single-strand nuclease-sensitive regions, consistent with
more origins being activated (16), while a polarity or
position change of replication initiation was also observed
with transformation (17). Some of the studies found the
organization of DNA replication sites to be fundamentally
diﬀerentinnormalcomparedtoimmortalizedcelllines(18),
but others observed no such diﬀerences (19,20).
Interestingly, the parameters governing replication
kinetics are conserved between normal and transformed
cells (21). A diﬀerent chromatin organization and
rearrangements as well as diﬀerential nuclease sensitivity
between normal and transformed cells throughout the
progression of S-phase have been previously reported
(22,23). Furthermore, the replication timing of homolo-
gous loci was found to be more asynchronous in
samples derived from transformed cells relative to their
normal counterparts (24). In addition, overexpression of
ORC subunits and increased ORC–chromatin association
was observed in transformed compared to normal cells
(25). These ﬁndings indicate a complex inﬂuence of
cellular transformation on the expression and regulation
of ORC subunits, extending the potential link between
transformation and deregulation of pre-RC proteins as
well as the subsequent pathways they aﬀect (26–28)).
Consequently, it is reasonable to suppose that more
origins of DNA replication are used (activated) in trans-
formed than normal cells, hinting at the existence of
tumor-speciﬁc origins.
To date little is known about diﬀerential origin usage
between normal and transformed cells. Cellular transfor-
mation resulted in a 2-fold increase of initiation sites
(origins) (14,15) as well as a 2-fold increase in origin
activity in transformed compared to normal cells, such
as at the NOA3 origin (10), the origin at the c-myc locus
(11,12), and six origins along an  211-kb stretch on
human chromosome 19q13 (13). It was previously
reported that in normal skin ﬁbroblasts (NSFs) two prom-
inent replication initiation sites were detected in a 5-kb
region encompassing the ARSH1 locus, whereas in
HeLa cells, multiple replication initiation sites were
detected within the same region (29). Similarly, when
analyzing initiation sites in the vicinity of the putative
ribulose-5-phosphate 3-epimerase gene, NSF and normal
breast epithelial cells (MCF10) had one prominent initia-
tion site in a speciﬁc location, while HeLa cells revealed a
more zonal pattern of initiation within the same region
(30). There are origins, however, whose initiation
activity remains unaltered in the transformed state, such
as the well-characterized origin at the lamin B2 locus (31),
the origin at the b-globin locus and the 343 and S14
origins (10). Altogether, these results suggest that there
are at least three subsets of origins, those that are
normal and remain unchanged, those with increased
activity in transformed cells and those that are activated
exclusively in tumor cells.
In this study, we searched for transformation-speciﬁc
origins by examining the replication activity of several
clones obtained from previously generated libraries
enriched for human replication origins (32). Three clones
were able to replicate episomally solely in transformed
cells, but all three coincided with chromosomal origins
of DNA replication in both transformed and normal
cells, albeit with increased activity in the transformed
cells. Electrophoretic mobility shift assays (EMSAs)
using the most eﬃciently replicating clone revealed
transformation-speciﬁc complexes, which were analyzed
by mass spectrometry and identiﬁed potential new
proteins involved in DNA replication that correlate with
cellular transformation.
MATERIALS AND METHODS
Plasmid constructs
Plasmid constructs used in the transient replication assays,
such as pA3/4, pLB2 and pLB2C1 were described
previously (13), pCLONE 3, pCLONE 13 and pCLONE
32 were prepared by directionally cloning speciﬁcally
designed polymerase chain reaction (PCR) products
(Supplementary Table S1) prepared using a high ﬁdelity
Pfu DNA polymerase (Promega, San Luis Obispo, CA,
USA) into the BamHI and EcoRI sites of the
pBluescript vector (Stratagene, La Jolla, CA, USA),
using a standard protocol (33). Supercoiled plasmid
DNA of the resulting clones as well as the pM1 SEAP
vector (Roche Molecular Biochemicals, Indianapolis, IN,
USA) was prepared using the Qiagen Maxiprep kit
(QIAGEN, Mississauga, ON, Canada) according to man-
ufacturer’s speciﬁcations, and sequenced.
Cell culture and FACS analysis
HeLa, NSF (primary NSFs), WI38 (human lung embryo
ﬁbroblasts) and WI38 VA13 2RA (WI38 transformed
with SV40 virus) were acquired from American Type
Culture Collection (Manassas, VA, USA) and cultured
in a-minimal essential medium supplemented with penicil-
lin (100mg/ml), streptomycin (100mg/ml), 1mM L-
glutamine, tylosin (8mg/ml) and 10% (v/v) fetal bovine
serum. When the cells reached 30–50% conﬂuence, they
were harvested for the isolation of nascent DNA, while
upon reaching 60–80% conﬂuence, they were harvested
for isolation of chromatin immunoprecipitated DNA,
whereas upon reaching 100% conﬂuence, they were
serum-starved for 48–72h and harvested for the isolation
of genomic DNA. For ﬂow cytometry analysis, cells were
washed twice in ice-cold phosphate-buﬀered saline (PBS),
and resuspended in Vindelov’s solution (3.4mM Tris,
75mM propidium iodide, 0.1% NP40, 0.01M NaCl,
700U/l Rnase A), overnight at 4 C, then analyzed using
a Beckman ﬂow cytometer and the CellQuest program.
Episomal DNA replication (DpnI resistance) assay
For transfections, HeLa and NSF cells were seeded in
six-well plates at a density of 3 10
4 per well, and  16h
later were transfected with 3mg of supercoiled plasmid
DNA [2mg of each construct (pA3/4, pLB2, pLB2C1,
pCLONE 3, pCLONE 13, pCLONE 32) and 1mg pM1
SEAP], using FuGENE 6 transfection reagent (Roche
Molecular Biochemicals) as per manufacturer’s instruc-
tions. At 72h post-transfection, low-molecular-weight
DNA was isolated and half was digested with DpnI. The
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form the DH5a strain of Escherichia coli and the relative
in vivo DNA replication of each transfected plasmid
was determined by counting the number of colonies in a
bacterial retransformation assay, as previously described
(34). The levels of secreted human placental alkaline
phosphatase, determined by the SEAP Reporter Gene
Assay kit (Roche Molecular Biochemicals) as per manu-
facturer’s speciﬁcations, were used to normalize the
transfection eﬃciency.
Isolation of genomic DNA
Genomic DNA was isolated using the GenElute
Mammalian Genomic DNA Miniprep Kit (Sigma,
Oakville, ON, Canada), as per instructions of the
manufacturer.
Isolation of nascent DNA
Nascent DNA was prepared using the  -exonuclease
method, as previously described (11,12), with the follow-
ing modiﬁcations: The  -exonuclease digested samples
were heated at 100 C for 3min, then immediately sub-
jected to electrophoresis on a 2% agarose gel. DNA was
visualized by staining with 0.02% (w/v) methylene blue
(Sigma) and the origin-containing nascent DNA, ranging
between 350 and 1000bp in size was excised from the
gel, puriﬁed with the Sephaglas BandPrep Kit (GE
Healthcare, Piscataway, NJ, USA), as per instructions of
the manufacturer, and resuspended in TE.
Preparation of whole-cell extracts
For the preparation of whole-cell extracts (WCEs), the
cells were harvested, washed twice with ice-cold PBS and
resuspended in 2 packed cell volume (pcv) hypotonic
buﬀer [20mM HEPES-KOH, pH 7.9, 25% glycerol,
0.42M NaCl, 1.5mM MgCl2, 1% Triton X-100, 20mM
EDTA, 50mM DTT and complete protease inhibitor
tablet (Roche Molecular Biochemicals, Indianapolis,
IN, USA)]. Following a 1-h incubation at 4 Ci n
constant agitation, the cells were centrifuged at 14000g,
the supernatant harvested and its protein concentration
determined using the Bradford Protein Assay (Bio-Rad,
Hercules, CA, USA).
Chromatin loading
Cell fractionation and preparation of the chromatin-
enriched fractions were performed as previously described
(35). Cells were harvested from 10-cm dishes into ice-cold
PBS, centrifuged, resuspended in 1ml of lysis buﬀer A
[10mM HEPES-KOH, pH 7.9, 100mM NaCl, 300mM
sucrose, 0.1% Triton X-100 and complete protease inhib-
itor tablet (Roche Molecular Biochemicals)], and lysed on
ice for 10min. After centrifugation at 2000g for 3min at
4 C, pellets were washed once more with ice-cold lysis
buﬀer A and resuspended in lysis buﬀer B [10mM
HEPES-KOH, pH 7.9, 200mM NaCl, 300mM sucrose,
0.1% Triton X-100, 5mM MgCl2 and complete protease
inhibitor tablet (Roche Molecular Biochemicals)] contain-
ing 1000U of DNase I (Invitrogen). Following incubation
at 25 C for 30min, the chromatin-enriched fraction was
isolated in the supernatant after centrifugation at 2500g
for 5min at 4 C and its protein concentration was deter-
mined using the Bradford Protein Assay (Bio-Rad).
In vivo cross-linking and chromatin fragmentation
Cells cultured in complete media were washed with
pre-warmed PBS and treated with 1% formaldehyde for
10min to cross-link proteins and DNA in vivo (36); they
were then washed and scraped into ice-cold PBS and
resuspended in lysis buﬀer (50mM HEPES-KOH pH
7.5, 140mM NaCl, 1% Triton X-100, 2mM EDTA) sup-
plemented with a complete protease inhibitor tablet
(Roche Molecular Biochemicals). Following passage
through a 21-G needle three times, the nuclei were har-
vested, resuspended in one packed nuclear volume of lysis
buﬀer, and sonicated until DNA fragments of <1kb were
obtained. Chromatin size was monitored by electro-
phoresis. For cell counting, one untreated plate was
scraped into PBS and resuspended well. The cells were
then counted with a hematocytometer, and this number
was used to derive the total number of treated cells. In
addition, the concentrations of the extracts were deter-
mined using the Bradford protein assay (BioRad,
Hercules, CA, USA) in order to normalize samples
across cell lines.
Immunoprecipitation and DNA isolation
Immunoprecipitation (IP) was carried out as previously
described (36), with the following modiﬁcations: Brieﬂy,
sheared chromatin lysates (500mg) were pre-cleared by
incubation with 50ml of protein A/G agarose (Roche
Molecular Biochemicals) to reduce background caused
by non-speciﬁc adsorption to the beads, incubated for
6h with either 20mg of anti-ORC2 (Santa Cruz,
sc-32734), anti-cdc6 (Santa Cruz, sc-8341), anti-cdt1
(Santa Cruz, sc-28262), anti-EEF1D (gift from Dr.
William C. Merrick)/(Santa Cruz, sc-68483), anti-Fe65
(Santa Cruz, sc-33155), anti-FKBP-25 (Santa Cruz,
sc-81089), anti-REF-1 (Santa Cruz, sc-5572) or normal
rabbit serum (NRS) at 4 C with constant rotation.
Protein A/G agarose (50ml) was added and incubated
overnight at 4 C. The pelleted beads were washed succes-
sively twice with 1ml of lysis buﬀer for 15min each at 4 C,
followed by 1ml of WB1 (50mM Tris–HCl pH 7.5,
500mM NaCl, 0.1% NP40, 0.05% sodium deoxycholate,
complete protease inhibitor tablet), 1ml of WB2 (50mM
Tris–HCl pH 7.5, 0.1% NP40, 0.05% sodium
deoxycholate, complete protease inhibitor tablet) and
1ml of sterile TE. The beads were resuspended in 200ml
TE/1% SDS, incubated at room temperature (rt) for
15min and centrifuged at 3000r.p.m. for 1min at rt.
Half of the supernatant was then incubated overnight at
65 C to reverse the cross-links, followed by 100mgo f
proteinase K at 55 C for 2h. The DNA was puriﬁed
using QIAquick PCR puriﬁcation kit (Qiagen, Valencia,
CA, USA) and eluted in 100ml TE. The remaining half of
the supernatant was boiled for 10min in SDS-PAGE
loading buﬀer and subjected to electrophoresis on a 5%
2316 Nucleic Acids Research, 2010,Vol.38, No. 7stacking/8% separating SDS-PAGE gel for western blot
analysis.
Western blot analysis
Western blot analysis was carried out according to
standard protocols (33). Brieﬂy, the indicated amounts
of WCEs, chromatin-enriched fractions, cross-linked
immunoprecipitated samples and the EMSA samples
obtained for the veriﬁcation of the proteins identiﬁed in
the complex by mass spectrometry were resuspended in
SDS loading buﬀer (50mM Tris–HCl, pH 6.8, 100mM
DTT, 2% SDS, 0.1% bromophenol blue, 10% glycerol),
boiled for 10min and loaded onto a 5% stacking/8%
separating SDS-PAGE gel. Following electrophoresis
and transfer onto a PVDF membrane, the membrane
was immunoblotted with the indicated primary and corre-
sponding HRP-conjugated secondary antibodies. The
following antibodies were used: a 1/500 dilution of
anti-ORC2 (Santa Cruz, sc-32734), anti-cdc6 (Santa
Cruz, sc-8341), anti-cdt1 (Santa Cruz, sc-28262),
anti-EEF1D (gift from Dr. William C. Merrick)/(Santa
Cruz, sc-68483), anti-Fe65 (Santa Cruz, sc-33155),
anti-FKBP-25 (Santa Cruz, sc-81089), anti-ORC1 (Santa
Cruz, sc-23887) and a 1/1000 dilution of anti-REF-1
(Santa Cruz, sc-5572) and anti-actin (Sigma, A2066).
Proteins were visualized using the enhanced
chemiluminescence kit according to the manufacturer’s
instructions (Amersham Biosciences, Arlington Heights,
IL, USA).
Real-time PCR quantiﬁcation analyses
PCRs were carried out in a total volume of 20ml with
5ml of genomic, nascent or immunoprecipitated DNA,
using the LightCycler (Roche Diagnostics), as previously
described (13). The sequences and ampliﬁcation condi-
tions for all primer sets are shown in Supplementary
Table S2. Genomic DNA (1, 2, 3 and 4ng) from NSF
cells was used to generate the standard curves needed
for quantiﬁcation of the PCR products. A negative
control without template DNA was included with each
set of reactions. PCR products were also resolved on
2% agarose gels, visualized with ethidium bromide, and
photographed with an Eagle Eye apparatus (Speed Light/
BT Sciencetech-LT1000). No extraneous bands were
generated with any of the primer sets.
Nuclear extract preparation
Cells cultured in complete media were harvested, washed
once with complete medium and twice with PBS. The
pelleted cells were resuspended in buﬀer 1 (100mM
Tris–HCl pH 7.4, 100mM NaCl, 30mM MgCl2, 0.5%
NP40, 0.5mM DTT, complete protease inhibitor tablet),
incubated for 5min at 4 C and pelleted by centrifugation
for 5min at 1500r.p.m. to separate them from the
cytoplasmic fraction. The remaining nuclei were washed
with buﬀer 1, then resuspended in buﬀer 2 (20mM
HEPES pH 7.4, 0.42M NaCl, 1.5mM MgCl2, 0.2mM
EDTA, 25% glycerol, 0.5mM DTT, complete protease
inhibitor tablet) and incubated at 4 C for 40min and
ﬁnally spun for 10min at 4 C (14000r.p.m.). The
concentrations of the nuclear extracts (NEs) were deter-
mined using the Bradford protein assay (BioRad).
EMSA
The genomic region corresponding to the clone 3 ori-
gin sequence (probe 3P) (AL031123.14 nucleotides
67323–67467) and non-origin sequence (probe 3C)
(AL031123.14 nucleotides 68610–68786) were ampliﬁed
by PCR and
32P-end-labeled by the enzymatic activity
of T4 polynucleotide kinase. NEs (10mg) prepared from
each cell line were incubated with 0.4fmol of
32P-labeled
probes 3P or 3C, in the presence of 1mg non-speciﬁc inhib-
itor poly(dI–dC) (Amersham Biosciences), and the
binding reaction was performed in binding buﬀer
(10mM Tris–HCl, pH 7.5, 80mM NaCl, 1mM EDTA,
10mM b-mercaptoethanol, 0.1% Triton X-100, 4%
glycerol) for 1h on ice. Subsequently, the mixtures were
subjected to electrophoresis on a native 5% PAGE at
140V in 0.5 TBE and the gels were then dried and sub-
jected to autoradiography. For the competitive EMSA,
increasing molar excess amounts of cold speciﬁc probe
3P or non-speciﬁc probe 3C were included in the reactions.
For the supershift EMSA, 4mg of anti-ORC1 (Santa Cruz,
sc-23887/sc-28741), anti-ORC2 (Santa Cruz, sc-13238),
anti-ORC3 (Santa Cruz, sc-23888), anti-ORC4 (Santa
Cruz, sc-20634), anti-ORC5 (Santa Cruz, sc-20635),
anti-cdc6 antibodies (Santa Cruz, sc-8341/sc-9964) or
NRS were added to the EMSA reaction for two additional
hours after the binding reaction.
In-solution digest
Gel pieces were destained (100mM ammonium bicarbon-
ate pH8, acetonitrile) then dehydrated with acetonitrile.
Samples were reduced (in the dark) with 50ml DTT for
30min followed by alkylation with 50ml iodoacetamide
(20min). Protein digestion was done for 4.5h with 6ng/
ml of trypsin Gold (Promega) in 100mM ammonium
bicarbonate. Peptides were extracted with 30ml formic
acid (FA) solution [1% FA: 2% acetonitrile (Acn)] for
30min followed by two 1% FA: 50% Acn solutions for
30min.
Chromatography
Sample injection and HPLC separation was performed
using an Agilent 1100 series system. Twenty microliters
of digest solution was loaded onto a Zorbax 300SB-C18
5 0.3mm trapping column then washed for 5min at
15ul/min with 3% Acn:0.1% FA. Nano-HPLC peptide
separation was done using a New Objective (Woburn,
MA, USA) Biobasic C18 10 0.075mm picofrit analytical
column. The gradient was 10% Acn:0.1% FA to 95%
Acn:0.1% FA in 30min at 200nl/min.
Mass spectrometry
The instrument used was a Micro-Qtof from Waters
(Milford, MA, USA). Data-dependent analysis was done
on the most intense ions from each full scan mass
spectrometry (MS) with dynamic exclusion for 60s.
Simple MS scan range was from 350 to 1600m/z for 1s.
Nucleic Acids Research,2010, Vol.38, No. 7 2317MS/MS data was acquired for up to three 1-s scans from
50 to 2000m/z.
Database searches
Peak picking for MS/MS peaklist generation was done
with Mascot distiller 2.1 from Matrixscience (Boston,
MA, USA). Protein identiﬁcation was done with Mascot
2.1 by searching against sequences from the July 2007
NCBInr database, Mascot results were processed using a
bio-informatics program (CellMapBase) used to cluster
and group peptides and proteins based on peptides
identiﬁed at the 95% conﬁdence level by Mascot so as
to generate a non-redundant minimal list of identiﬁed
proteins.
RESULTS
Location of clones 3, 13 and 32 within the human genome
Clones 3, 13 and 32 used in this study were derived from
libraries enriched for human origins of DNA replication
previously generated in our laboratory (32). These
sequences were subjected to a BLAST search to reference
them against GenBank nucleotide databases that were
obtained from the National Center for Biotechnology
Information (NCBI) in order to determine the location
of the clones within the human genome. Clone 3 is a
690-bp sequence located on chromosome 6, clone 13 is a
1727-bp sequence located on chromosomes 1 and 4 (the
two sequences located within these chromosomes are 99%
homologous), and clone 32 is a 247-bp sequence located
on chromosome 2 (Table 1).
Autonomous replication activity of plasmids containing
clones 3, 13 and 32
The ability of clones 3, 13 and 32 to confer autonomous
replication activity when cloned into a plasmid was
analyzed by the DpnI-resistance assay, which is an
indicator of semiconservative DNA replication, as
previously described (34).
HeLa (transformed) and NSF (normal) cells were
transfected with one of the following constructs: pA3/4,
containing a version of the 36-bp mammalian consensus
[positive control; (37)]; pLB2, an origin containing
sequence within the lamin B2 locus [positive control;
(13)]; pLB2C1, a non-origin containing sequence within
the lamin B2 locus [negative control for the lamin B2
locus; (13,38)]; pCLONE 3, containing clone 3;
pCLONE 13, containing clone 13; pCLONE 32, contain-
ing clone 32; pBluescript vector without an insert (negative
control); also pM1 SEAP vector was co-transfected with
each construct to normalize for the transfection eﬃciency;
ﬁnally, a mock transfection without a construct was
done as an additional negative control. At 72h
post-transfection, plasmid DNA was isolated, digested
with DpnI and the DpnI-digested DNA was used to trans-
form E. coli. After 18h, the number of colonies produced
was counted, corrected for the amount of DNA recovered,
and related to the most eﬃciently replicating plasmid
in both cell lines (pA3/4), which was taken as 100%
(Figure 1). Interestingly, all three clones conferred auton-
omous replication activity to their respective plasmids
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Figure 1. Episomal replication activity of clones 3, 13 and 32 in HeLa and NSF cells. Histogram plot of the number of bacterial colonies produced
after transformation of E. coli with DpnI-digested Hirt extracts of HeLa and NSF cells transfected for 72h with one of the following constructs:
pA3/4, pLB2, pLB2C1, pCLONE 3, pCLONE 13 and pCLONE 32. The average number of DpnI-resistant colonies per plate was corrected for the
amount of DNA recovered and normalized to the number of colonies obtained with pA3/4 (most eﬃciently replicating clone), which was taken as
100%. The number at the bottom of each bar denotes the average number of colonies obtained from three experiments. The error bars represent the
average of three experiments performed in triplicate and 1 SD.
Table 1. Location of clones 3, 13 and 32 within the human genome
Clone
name
Genbank
Accession
No.
a
Nucleotide location
(bp) on (+) or (–)
strand (50 ! 30)
b
Length (bp)
3 AL031123.14 67215-67904 690
13 AC092670.2/
AC092782.2
62462-64188/
90186-88460
1727
32 AC023672.9 19334-19580 247
aNucleotide blast revealed that for clone 13, initially found within
AC092670.2 was also found at 99% homology within AC092782.2
bNucleotide position 50! 30 of each clone sequence (ascending numbers
indicate presence on the+strand and descending numbers indicate
presence on the   strand) (strand labeling is arbitrary)
2318 Nucleic Acids Research, 2010,Vol.38, No. 7solely in HeLa and not in NSF cells, suggesting that the
chromosomal sequences contained in these clones may
represent transformation-speciﬁc origins. In HeLa cells,
the plasmids containing clone 3 replicated with a 3-fold
higher eﬃciency by comparison to clones 13 and 32, which
replicated with equal eﬃciency. In contrast, pLB2 was able
to replicate autonomously at nearly the same eﬃciency in
both HeLa and NSF cells, unlike pLB2C1, which was
unable to replicate autonomously in either cell line.
Similarly, no bacterial colonies were obtained with
DpnI-digested DNA recovered when either the backbone
vector (pBluescript) had been transfected, as before (34), or
from the mock transfections. A relatively small number of
colonies (ranging from  7t o 34) was produced, on
average, by even the most eﬃciently replicating plasmid
(pA3/4 produced 33.5 colonies), as expected of mammalian
replication origins, which are activated only once per cell
cycle. This ‘low’ signal may also be the result of weaker
replication activity, resulting from the insert lacking
sequences that would normally be present on the chromo-
somal DNA, whose presence may be necessary to increase
replication eﬃciency (39).
Copy number of clone 3, 13 and 32 chromosomal sites
To assess the copy number per haploid genome of all
regions examined in this study, equal amounts of
genomic DNA from each cell line was ampliﬁed by
real-time PCR. Figure 2 (top sections of panels A–C),
shows representative ethidium bromide-stained 2%
agarose gels of the expected ampliﬁcation products of
362bp, 270bp and 425bp, obtained with the 3M, 13M
and 32M primer sets (Supplementary Table S2) of clones
3, 13 and 32, respectively. The histograms depicted in
Figure 2 (bottom sections of panels A–C), were
produced after normalization of the results by making
NSF equal to one copy per haploid genome (3M and
32M) or two copies per haploid genome (13M), as
sequence veriﬁcation of the chromosomal locus of clone
13 by BLAST analysis revealed its presence twice in the
genome (on chromosomes 1 and 4 at a level of 99%
homology). The results show that in all cell lines 3M
and 32M were present at one copy per haploid genome,
while 13M was present at two copies per haploid genome.
Similar results were obtained for all primer sets amplifying
these regions in every cell line examined in this study (data
not shown), indicating that all the 3 and 32 primer sets
target a single chromosomal locus per haploid genome
and all 13 primer sets target two chromosomal loci per
haploid genome.
Nascent DNA abundance
The above results allowed quantitative comparisons
between the nascent DNA abundance among the trans-
formed and normal cell lines, thus permitting measure-
ments of replication origin activity.
Nascent DNA was prepared by the  -exonuclease
method. Brieﬂy,  -exonuclease digests the 50 phosphory-
lated parental and broken DNA strands, but the nascent
DNA strands bearing 50 RNA primers are resistant to
digestion by this enzyme (11). Representative results of
all nascent DNA preparations carried out for each cell
line are shown in Figure 2D. Total cellular DNA
(together with total RNA) was isolated and sheared with
a ﬁne needle. The average size of the sheared total cellular
DNA was  30kb, seen as a band on a 1% agarose gel,
whereas the smear of lower molecular weight represented
RNA (Figure 2D, lane 2). Phosphorylation and
 -exonuclease digestion were monitored by an internal
control of dephosphorylated linear plasmid (Figure 2D,
lane 3); the plasmid DNA was completely phosphorylated
and digested by  -exonuclease (Figure 2D, lane 3 versus
lane 4), and residual RNA (Figure 2D, lane 4) was
removed by RNase A digestion (Figure 2D, lane 5).
To eliminate any Okazaki fragments that might contami-
nate the nascent DNA preparations, the samples were sub-
jected to electrophoresis on agarose gel, stained with
methylene blue, and only nascent DNA ranging between
350 and 1000bp was excised from the gel and puriﬁed.
To assess the quality of nascent DNA samples, the dis-
tribution of nascent DNA from an origin region
associated with the lamin B2 locus was quantiﬁed. This
origin has been shown to be constitutively active in a
number of diﬀerent proliferating human cells (11–
13,31,38). Nascent DNA was measured at two reference
points, one located at the center of the origin, (LB2 primer
set=peak activity) and the other located  4kb away
from it (LB2C1 primer set=background activity). The
ratio of highest to lowest abundance in the region to be
studied is indicative of the quality of the nascent DNA
preparation and signal-to-noise estimates (11,12,31).
Moreover, a ratio of signals from the initiation site to
distant non-initiation sites of  10, is indicative of good
quality nascent DNA (40). The ratio of highest abundance
at the lamin B2 peak region to lowest abundance at the
lamin B2 control region ranged from 10.2 to 13.7,
indicating good-quality nascent DNA preparations for
all cell lines (Figure 2E), and thus suitable for mapping
replication origins in vivo. These samples were used to mea-
sure the nascent DNA abundance across the chromosomal
loci that coincided with the sequences of clones 3, 13 and
32, in each of the transformed and normal cell lines.
Origin activities at the chromosomal loci of clones 3, 13
and 32 in transformed and normal cell lines
Origin activity in vivo was measured in two transformed
[HeLa and WI38(SV40)] and two normal (NSF and WI38)
human cell lines, by quantiﬁcation of nascent DNA
abundance across the chromosomal loci of clones 3
(Figure 3A), 13 (Figure 3B) and 32 (Figure 3C). Each of
the 15 primer sets used ampliﬁed a fragment of  200–
400bp in size (Supplementary Table S2). Chromosomal
nascent DNA abundance at each locus corresponding to
clones 3, 13 and 32 was measured using ﬁve primer sets:
M, which ampliﬁes a region containing part of the
autonomously replicating sequence (Table 1); L, which
ampliﬁes a region located  500–1000bp 50 (upstream) of
the M region; R, which ampliﬁes a region located  500–
1000bp 30 (downstream) of the M region; FL, which
ampliﬁes a region located  5–7kb 50 (upstream) of the
M region; and FR, which ampliﬁes a region located
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Figure 2. Copy number per haploid genome of clones 3, 13 and 32 at their respective chromosomal loci in normal and transformed cell lines (A–C)
and nascent DNA preparation (D, E). (Top section of A–C) PCR ampliﬁcation products (362bp, 425bp, 270bp) produced by primer sets 3M, 13M
and 32M, respectively, resolved on a 2% agarose gel and stained by ethidium bromide. Template DNA was as follows: lanes 1–3, genomic DNA (1,
2, 3ng, respectively) from NSF cells [used to build the standard curve for quantiﬁcation of DNA by real-time PCR; positive control (+ve)]; lanes
4–7, 10ng of genomic DNA from: HeLa, NSF, WI38, WI38(SV40) cells; lane 8, water [no template DNA added; negative control ( ve)]. (Bottom
2320 Nucleic Acids Research, 2010,Vol.38, No. 7section of A–C) Histogram plot of copy number/haploid genome of clones 3, 13 and 32 in all cell lines used in the study. The results were normalized
by making NSF equal to one copy/haploid genome for primer sets 3 and 32 (or equal to two copies/haploid genome for primer set 13). The error
bars represent the average of at least two experiments performed in triplicate and 1 SD. (NB: these are representative graphs, as the copy number of
all the primer sets used in this study was measured; Supplementary Table S2.) (D) Nascent DNA preparation. Lane 1: GeneRuler DNA Ladder Mix;
lane 2:  600ng total cellular (DNA+RNA) sheared with a ﬁne needle (26G3/8); lane 3:  1200ng sheared and denatured total cellular
(DNA+RNA); the single band was the internal control, linear pCR-XL-TOPO ( 50ng); lane 4: sheared total cellular (DNA+RNA) and
internal linear control digested by  -exonuclease; lane 5: the nascent DNA sample after further treatment with RNase A; lane 6:
HindIII-digested   phage DNA marker. The nucleic acids were separated by electrophoresis on a 1% agarose native gel. (E) Assessment of
quality of nascent DNA, exempliﬁed by the lamin B2 origin, in HeLa, NSF, WI38 and WI38(SV40) cells. Histogram plot of the nascent DNA
abundance (ng), measured by real-time PCR, at the lamin B2 peak region (dark gray) and a non-origin-containing (control) region, located  4kb
downstream (light gray). The error bars represent the average of at least two experiments performed in triplicate and 1SD.
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Figure 3. Nascent DNA abundance of clones 3, 13 and 32 at their respective chromosomal loci in normal and transformed cell lines. Histogram
plots of the quantiﬁcation by real-time PCR of nascent DNA abundance (ng) at the chromosomal loci of clones 3, 13 and 32, respectively, of two
transformed [HeLa and WI38(SV40)] (gray bars) and two normal (NSF and WI38) (white bars) cell lines. Each of the 15 primer sets ampliﬁes a
region of  200–400bp in size: M, a region containing the autonomously replicating sequence (predicted origin sequences) of clone 3 (A),1 3(B) and
32 (C); L, a region located  500–1000bp 50 (upstream) of the M region; R, a region located  500–1000bp 30 (downstream) of the M region; FL
(negative control), a region located  5–7kb 50 (upstream) of the M region; FR (negative control), a region located  5–7kb 30 (downstream) of the M
region. For the location of all primers used in the study, see Supplementary Table S2. The error bars represent the average of at least two
experiments performed in triplicate and 1 SD.
Nucleic Acids Research,2010, Vol.38, No. 7 2321 5–7kb 30 (downstream) of the M region. The FL and FR
primers, designed to amplify regions not containing repli-
cation origins (negative controls), were used to measure
the lowest abundance of nascent DNA at the chromo-
somal loci of their respective clones.
The nascent strand abundance across the chromosomal
loci of clones 3, 13 and 32 was determined in the same
preparation of short nascent DNA and normalized to that
of an internal reference, the lamin B2 locus, to control for
the possibility of a greater recovery of nascent DNA from
the transformed cells compared to the normal ones.
Speciﬁcally, ampliﬁcation of nascent DNA with primer
set LB2C1 (background activity compared to lamin B2
peak region, primer set LB2) gave baseline values that
were used to normalize results from all the nascent DNA
preparations of all cell lines, permitting comparison of data
between diﬀerent preparations and diﬀerent cell lines.
Histogram plots of the nascent DNA abundance
measured across the chromosomal loci of clones 3
(Figure 3A), 13 (Figure 3B) and 32 (Figure 3C) in all
the cell lines used show a peak of origin activity at the
M region of each clone, decreasing to  71–53% less origin
activity at the L & R regions immediately ﬂanking the M
region and reaching background levels  10% or less
origin activity at the FL & FR negative regions located
at least 5kb away from any of the M regions. These data
indicate that the M region of each clone is located at a site
of initiation (origin) of DNA replication.
The results also indicated a 2–3-fold higher origin
activity in the transformed cell lines compared to the
normal ones, suggesting a transformation-related activa-
tion of these origins. The same result was obtained with
the isogenic pair of WI38 (normal) and WI38(SV40)
(transformed) cells, ruling out the possibility that the
observed increased frequency of initiation in the trans-
formed cell lines might be due to cell type. In all the cell
lines examined, the highest abundance of nascent DNA
was located at the position of primer set 3M, then 13M
and ﬁnally 32M, suggesting that clone 3 was the most
eﬃcient replication origin, followed by the clone 13
origin and ﬁnally the clone 32 origin. Moreover, the
lowest abundance was located at the position of the FL
& FR primer sets for all three clones (Figure 3A–C),
which is most distant from any M region, indicating that
no origins were located at these regions. Furthermore, for
all three clones the ratio of the highest abundance at
primer set M to lowest abundance at primer set FL/FR
for all the cell lines ranged from 10.4 to 21.0 (clone 3), 11.0
to 18.1 (clone 13) and 10.4 to 21.4 (clone 32), indicating
that all the nascent DNA preparations were of good
quality. Finally, all clones exhibited ratios of highest
abundance (peak activity) to lowest abundance (back-
ground activity) of values >10, conﬁrming that these are
true start sites of DNA replication (40).
In vivo association of ORC2, cdc6 and cdt1 at the
chromosomal loci of clones 3, 13 and 32 in
transformed and normal cell lines
The in vivo association of ORC2, cdc6, and cdt1 was
measured in the transformed [HeLa and WI38(SV40)]
and normal (NSF and WI38) cell lines, by quantiﬁcation
of chromatin immunoprecipitated DNA corresponding to
the origin regions (3M, 13M and 32M) of the three clones
(3, 13 and 32, respectively) compared to non-origin
containing (control) regions (3FR, 13FR and 32FR)
(Figure 4A–C). The cell cycle distribution of a population
of asynchronously growing cells from all cell lines was
found to be the same by FACS analysis (Supplementary
Figure S1), permitting the subsequent comparisons
between the cell types. Equal amounts of cross-linked
chromatin extracts (500mg) were immunoprecipitated
with anti-ORC2, anti-cdc6 and anti-cdt1 antibodies and
an equivalent amount of NRS as a negative control to give
baseline values that were used to normalize results from all
ChIP preparations of all cell lines, permitting comparison
of data between diﬀerent preparations and diﬀerent
cell lines. Immunobloting of the immunoprecipitated
lysates veriﬁed that all antibodies did immunoprecipitate
their respective proteins in all cell lines, while no proteins
were immunoprecipitated by the NRS, indicating the
speciﬁcity of the IP reactions (Figure 4D).
Histogram plots of the immunoprecipitated DNA
abundance of ORC2, cdc6 and cdt1 measured at the chro-
mosomal loci of clones 3 (Figure 4A), 13 (Figure 4B) and
32 (Figure 4C) in all the cell lines used show an increased
in vivo association of ORC2, cdc6 and cdt1 at each of the
origin sequences (M region) of the three clones compared
to non-origin sequences (FR region) located at least 5kb
away from any of the origins. The association of ORC2,
cdc6 and cdt1 to the clone 3 origin varied from 5.9- to
17.2-fold enrichment over NRS and was 5.5- to 12.2-
fold greater than the non-origin containing sequence
(Figure 4A), while their association to the clone 13
origin varied from 5.3- to 14.8-fold enrichment over
NRS and was 4.9- to 12.4-fold greater than the non-origin
containing sequence (Figure 4B), and their association to
the clone 32 origin varied from 5.8- to 20.7-fold enrich-
ment over NRS and was 6.1- to 14.5-fold greater than the
non-origin containing sequence (Figure 4C). The low
abundance of DNA detected in the NRS immunopre-
cipitates indicated that the ChIP conditions were stringent
enough to prevent substantial non-speciﬁc association of
DNA with the immunoglobulins or agarose beads.
The results also indicated a 2- to 3-fold higher in vivo
association of ORC2, cdc6 and cdt1 in the transformed
cell lines compared to the normal ones, suggesting a
transformation-related increased association of these ini-
tiator proteins with the origins located at the chromo-
somal loci of clones 3, 13 and 32. Use of the isogenic
pair of WI38 and WI38 (SV40) showed that the origins
were bound by at least twice as much ORC2, cdc6 and
cdt1 in the transformed compared to the normal cell lines,
again ruling out the possibility that the observed increased
binding of these pre-RC proteins in transformed cells
might be due to cell type. In all the cell lines examined,
the highest binding of ORC2, cdc6 and cdt1 was obtained
at the clone 3 origin, followed by the clone 13 origin and
lastly the clone 32 origin, in agreement with their replica-
tion proﬁle (Figure 3A–C). Background levels of ORC2,
cdc6 and cdt1 were observed at the position of the FR
primer sets, which is most distant from any clone origin,
2322 Nucleic Acids Research, 2010,Vol.38, No. 7conﬁrming that no origins were located at these regions
(Figure 3A–C).
MS analysis of replication complexes formed on the
origin sequence of clone 3
In view of clone 3 being the most active replication origin
and its higher association with the pre-RC proteins
(ORC2, cdc6 and cdt1), it was further analyzed by
EMSA to ﬁnd out whether additional proteins bound to
this region. Equal amounts of nuclear extract from the
transformed and normal cell lines were incubated with
radioactive probe 3P (a subset of region 3M) or radioac-
tive probe 3C (a non-origin containing sequence that has
a similar AT content as probe 3P). EMSA analyses
(Figure 5A) revealed the formation of protein–DNA
complexes on both probes in all cell lines (Figure 5A,
lanes 2–5 and 7–10, complex indicated by arrow
asterisk), but additional protein–DNA complexes could
be detected on probe 3P (Figure 5A, lanes 2–5, complexes
indicated by arrows 1 and 2) and not on probe 3C (Figure
5A, lanes 7–10), which were prominent in the transformed
(Figure 5A, lanes 2 and 3), but barely detectable in the
normal (Figure 5A, lanes 4 and 5) cells. Competitive
EMSA analyses (Figure 5B) showed that the DNA–
protein complexes formed solely on probe 3P (complexes
1 an 2 indicated by arrows) were sequence speciﬁc, as
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Figure 4. In vivo association of ORC2, cdc6 and cdt1 to the chromosomal loci of clones 3, 13 and 32 in normal and transformed cell lines.
Histogram plots of the quantiﬁcation by real-time PCR of immunoprecipitated DNA abundance (ng) at the chromosomal loci of clones 3 (A),
13 (B) and 32 (C) respectively, in two transformed cell lines [HeLa and WI38(SV40)] and two normal cell lines (NSF and WI38). Chromatin IP was
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bars) was used as a negative control. The primer sets of clones 3 (A), 13 (B) and 32 (C) are explained in the legend of Figure 3 and Supplementary
Table S2. The error bars represent the average of at least two experiments performed in triplicate and 1 SD. (D) Western blot analysis using
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Figure 5. Formation of DNA replication complexes on the clone 3 origin containing sequence. (A) EMSA showing the formation of protein–DNA
complexes on probe 3P (ori) and probe 3C (control); 0.4 fmol of radiolabeled probes 3P (lanes 1–5) or 3C (lanes 6–10) was incubated with 10mgo f
NEs prepared from HeLa (lanes 2 and 7), WI38(SV40) (lanes 3 and 8), WI38 (lanes 4 and 9), NSF (lanes 5 and 10) cells and then subjected to
non-denaturing polyacrylamide electrophoresis. Complexes 1 and 2 (indicated by arrows) represent protein–DNA complexes that only form in the
presence of probe 3P and not probe 3C, while complex asterisk (indicated by an arrow) represents a non-speciﬁc protein–DNA complex formed in
the presence of both probes 3P and 3C. (B) Competition EMSAs showing the sequence speciﬁcity of the protein-DNA complexes 1 and 2 but not
complex asterisk formed onto probe 3P (lanes 1 and 7) in (i) HeLa (lanes 2–6) and WI38(SV40) (lanes 8–12) NEs and in (ii) WI38 (lanes 2–6) and
NSF (lanes 8–12) NEs. Inset shows a magniﬁcation of the area of interest in Figure 5Bii. (C) Supershift EMSAs showing that the protein-DNA
complex 1 on probe 3P (ori) contains pre-RC proteins in (i) HeLa and (ii) WI38(SV40) NEs (compare complex 1 to its supershifted position S1), but
not in (iii) WI38 and (iv) NSF NEs. Lane 1: Probe 3P alone; lane 2: Probe 3P incubated with NRS; lane 3: Probe 3P incubated with NEs; lane 4:
Probe 3P incubated with NEs+NRS; lane 5: Probe 3P incubated with NEs+anti-ORC1; lane 6: Probe 3P incubated with NEs+anti-ORC1; lane
7: Probe 3P incubated with NEs+anti-ORC2; lane 8: Probe 3P incubated with NEs+anti-ORC3; lane 9: Probe 3P incubated with
NEs+anti-ORC4; lane 10: Probe 3P incubated with NEs+anti-ORC5; lane 11: Probe 3P incubated with NEs+anti-cdc6. Probe incubated
with NRS and probe incubated with NEs and NRS were used as controls to conﬁrm the speciﬁc binding of the antibodies.
2324 Nucleic Acids Research, 2010,Vol.38, No. 710- to 50-fold excess of cold probe 3P (origin sequence),
but not of cold probe 3C (non-origin sequence), could
eﬃciently compete the formation of these complexes
(Figure 5B i and ii, lanes 2–6 and 8–12, respectively).
In contrast, the lower complex asterisk was found to be
sequence non-speciﬁc since its formation was similarly
competed by the speciﬁc (3P) and non-speciﬁc (3C)
probes (Figure 5B i and ii, lanes 2–6 and 8–12, respec-
tively). This is in agreement with its formation when 3C
was used as a probe in EMSA Figure 5A, lanes 7–10.
Supershift EMSA analyses (Figure 5C) were performed
using antibodies against various members of the pre-RC
(ORC1-5 and cdc6), after the incubation of probe 3P with
transformed (Figure 5C i and ii) and normal (Figure 5C iii
and iv) NEs. The results (Figure 5C i and ii) showed that
the addition of anti-ORC1, anti-ORC2 (lanes 5–7) and
anti-cdc6 (lane 11) antibodies resulted in a supershift of
the complexes formed [Figure 5C i and ii, compare
complex 1 (lanes 3 and 4) to complex S1 (lanes 5–7 and
11), indicated by arrows] indicating the presence of these
proteins in complex 1 within the transformed NEs. In
contrast, addition of the same antibodies did not change
the mobility of the complex ‘1’ formed within the normal
NEs (Figure 5C iii and iv, compare lanes 3 and 4 to lanes
5–7 and 11) indicating that these proteins were not present
in the complex, but only resulted in its stabilization due to
the eﬀect that the BSA contained in the antibodies has on
the stability of some protein–DNA interactions. Addition
of NRS to probe 3P alone or to probe 3P and NEs
(Figure 5C i–iv, lanes 2 and 4, negative controls) as well
as of anti-ORC 3,4,5 antibodies (Figure 5C i–iv, lanes
8–10), did not aﬀect the mobility of the complexes con-
ﬁrming the antibody speciﬁcity of the supershift.
The inability of the anti-ORC 3,4,5 antibodies to
supershift the complex may reﬂect the unavailability of
the antibody-targeted protein epitope due to the confor-
mation of the proteins. To determine the composition of
the transformation-speciﬁc complex, multiple bands cor-
responding to the most prominent supershift (Figure 5C i
and ii, lane 11) (T) obtained with transformed NEs and
the exact same portion of the gel (Figure 5C iii and iv, lane
11) (N) using normal NEs as well as the exact same
portion of the gel in a non-supershift reaction using trans-
formed NEs (negative control) (C) were excised from the
gel and analyzed by mass spectrometry to verify the con-
stituents of the complex. The following proteins were
identiﬁed uniquely in the DNA replication complex
obtained from lane 11 of Figure 5C i and ii of the trans-
formed cells: Ku86, DNA-PKcs, Fe65, REF-1, U5
snRNP-speciﬁc 200kD protein, FKBP-25 and EEF1D
(Table 2 for more information), while the composition
of the transformation-speciﬁc complex was also veriﬁed
by western blot (Figure 6A and B) showing the presence
of the above-mentioned proteins in the T but not the N or
C samples, indicating their involvement in DNA replica-
tion during cellular transformation.
Endogenous comparative analysis of the newly identiﬁed
proteins in transformed and normal cells
To assess the expression levels of these proteins, increasing
amounts of WCEs from transformed [HeLa and
WI38(SV40)] and normal (NSF and WI38) cells were
immunoblotted for Fe65, REF-1, FKBP-25 and EEF1D
(Figure 7A). All these proteins had a higher level of
expression in transformed compared to normal cells,
HeLa
P
r
o
b
e
 
3
P
+
 
N
R
S
+
 
H
e
L
a
 
N
E
s
+
 
N
R
S
 
+
 
H
e
L
a
 
N
E
s
+
 
a
n
t
i
-
O
R
C
1
+
 
a
n
t
i
-
O
R
C
1
+
 
a
n
t
i
-
O
R
C
2
+
 
a
n
t
i
-
O
R
C
3
+
 
a
n
t
i
-
O
R
C
4
+
 
a
n
t
i
-
O
R
C
5
+
 
a
n
t
i
-
C
d
c
6
i
WI-38 (SV-40)
P
r
o
b
e
 
3
P
+
 
N
R
S
+
 
W
I
-
3
8
 
(
S
V
-
4
0
)
 
N
E
s
+
 
N
R
S
+
W
I
-
3
8
(
S
V
-
4
0
)
N
E
s
+
 
a
n
t
i
-
O
R
C
1
+
 
a
n
t
i
-
O
R
C
1
+
 
a
n
t
i
-
O
R
C
2
+
 
a
n
t
i
-
O
R
C
3
+
 
a
n
t
i
-
O
R
C
4
+
 
a
n
t
i
-
O
R
C
5
+
 
a
n
t
i
-
C
d
c
6
ii
P
r
o
b
e
 
3
P
+
 
N
R
S
+
 
W
I
-
3
8
 
N
E
s
+
 
N
R
S
+
W
I
-
3
8
 
N
E
s
+
 
a
n
t
i
-
O
R
C
1
+
 
a
n
t
i
-
O
R
C
1
+
 
a
n
t
i
-
O
R
C
2
+
 
a
n
t
i
-
O
R
C
3
+
 
a
n
t
i
-
O
R
C
4
+
 
a
n
t
i
-
O
R
C
5
+
 
a
n
t
i
-
C
d
c
6
iii
WI-38
P
r
o
b
e
 
3
P
+
 
N
R
S
+
 
N
S
F
 
N
E
s
+
 
N
R
S
+
N
S
F
 
N
E
s
 
+
 
a
n
t
i
-
O
R
C
1
+
 
a
n
t
i
-
O
R
C
1
+
 
a
n
t
i
-
O
R
C
2
+
 
a
n
t
i
-
O
R
C
3
+
 
a
n
t
i
-
O
R
C
4
+
 
a
n
t
i
-
O
R
C
5
+
 
a
n
t
i
-
C
d
c
6
iv
NSF
S1
1
S1
1
C
1   2  3   4  5  6  7   8  9 10 11 1   2  3   4  5  6   7  8   9 10 11 1   2  3  4  5  6   7  8  9 10 11 1  2   3  4  5  6  7  8  9 10 11
2
*
2
*
1
* *
1
2 2
Figure 5. Continued.
Nucleic Acids Research,2010, Vol.38, No. 7 2325possibly accounting for the higher prevalence of this
complex in transformed compared to normal cells.
To assess the global chromatin association of these
proteins, increasing amounts of chromatin-enriched
extracts from transformed [HeLa and WI38(SV40)] and
normal (NSF and WI38) cells were immunoblotted for
Fe65, REF-1, FKBP-25 and EEF1D (Figure 7B). The
results showed that Fe65 had similar chromatin bound
levels in HeLa, WI38 and NSF cells, but increased in
WI38(SV40) cells; REF-1 and FKBP-25 had a higher
chromatin bound levels in transformed [HeLa and
WI38(SV40)] compared to normal cells (NSF and
WI38); and EEF1D had similar chromatin bound levels
in WI38 and WI38(SV40) cells, less so in NSF cells and the
most in HeLa cells.
The local origin-speciﬁc in vivo association of Fe65,
REF-1, FKBP-25, and EEF1D was measured in the trans-
formed [HeLa and WI38(SV40)] and normal (NSF and
WI38) cell lines, by quantiﬁcation of chromatin
immunoprecipitated DNA corresponding to the clone 3
origin region (3M) compared to non-origin containing
(control) region (3FR) (Figure 7C). Equal amounts of
cross-linked chromatin extracts (500mg) were immunopre-
cipitated with anti-Fe65, anti-REF-1, anti-FKBP-25
and anti-EEF1D antibodies and an equivalent amount of
NRS as a negative control. Immunoblots of the
immunoprecipitated lysates veriﬁed that all antibodies
did immunoprecipitate their respective proteins in all cell
lines (Figure 7D). No proteins were immunoprecipitated
by the NRS, indicating the speciﬁcity of the IP reactions.
Table 2. Proteins identiﬁed by mass spectrometric analysis of the transformation-speciﬁc DNA replication complexes obtained by means of the
supershift EMSA
Locus Symbol Oﬃcial full name Mass (kDa) Function Processes
P13010 XRCC5 X-ray repair complementing
defective repair in Chinese
hamster cells 5
(double-strand-break rejoining;
Ku autoantigen, 80kDa)
(Ku86)
82.7 ATP-binding / ATP-dependent
DNA helicase activity/DNA
binding/helicase activity/
hydrolase activity/nucleotide
binding/protein C-terminus
binding
double-strand break repair via
non-homologous end joining/
initiation of viral infection/
provirus integration / regula-
tion of DNA repair / DNA
replication
O00213 APBB1 amyloid beta (A4) precursor
protein-binding, family B,
member 1(Fe65)
77.0 beta-amyloid binding /
transcription factor binding
axonogenesis / cell cycle arrest /
negative regulation of S-phase
of mitotic cell cycle/negative
regulation of cell growth/
negative regulation of
thymidylate synthase biosyn-
thetic process/ regulation of
transcription / signal
transduction
P78527 PRKDC protein kinase, DNA-activated,
catalytic polypeptide
(DNA-PKcs)
469.1 ATP binding / DNA binding /
DNA-dependent protein kinase
activity / protein binding /
transferase activity
DNA recombination / DNA
repair /double-strand break
repair via non-homologous end
joining/ peptidyl-serine
phosphorylation/ protein modi-
ﬁcation process
Q5TZP7 APEX1 APEX nuclease (multifunctional
DNA repair enzyme) 1
(APEX-1) (REF-1)
35.6 30-50 exonuclease activity/DNA
binding/DNA-(apurinic or
apyrimidinic site) lyase activity/
endodeoxyribonuclease activity
/ lyase activity/magnesium ion
binding/oxidoreductase activity/
phosphodiesterase I activity/
protein binding/ribonuclease H
activity/transcription
coactivator activity/ transcrip-
tion corepressor activity/ uracil
DNA N-glycosylase activity
base-excision repair / regulation
of DNA binding/regulation
of cell redox homeostasis/
transcription from RNA
polymerase II promoter
O75643 ASCC3L1 activating signal cointegrator 1
complex subunit 3-like 1
(U5-200KD)(U5
snRNP-speciﬁc 200-kDa
protein)
244.5 ATP binding / ATP-dependent
helicase activity / hydrolase
activity / nucleic acid binding/
nucleoside-triphosphatase
activity/nucleotide binding /
protein binding
RNA splicing/cis assembly of
pre-catalytic spliceosome/
nuclear mRNA splicing,
via spliceosome
Q53GD8 FKBP3 FK506 binding protein 3
(FKBP-25)
25.2 FK506 binding/isomerase
activity/peptidyl-prolyl cis-trans
isomerase activity/receptor
activity
Protein folding
Q4VBZ6 EEF1D eukaryotic translation elongation
factor 1 delta (guanine
nucleotide exchange protein)
(EF-1D) (EEF1D)
28.6 protein binding/signal transducer
activity/translation elongation
factor activity
positive regulation of I-kappaB
kinase/NF-kappaB cascade/
translational elongation
2326 Nucleic Acids Research, 2010,Vol.38, No. 7Histogram plots of the immunoprecipitated DNA
abundance of Fe65, REF-1, FKBP-25 and EEF1D
measured at the chromosomal locus of clone 3
(Figure 7C) in all the cell lines used show an increased
in vivo association of Fe65, REF-1, FKBP-25 and
EEF1D at the clone 3 origin sequence (3M) compared
to the non-origin sequence (3FR) located at  6kb away
from the origin. The binding of Fe65, REF-1, FKBP-25
and EEF1D to the clone 3 origin varied from 6.6- to
19.5-fold enrichment over NRS for the transformed cells
and from 2.4- to 3.1-fold enrichment over NRS for the
normal cells, while it was 4.3–10.3-fold greater than the
non-origin containing sequence for the transformed cells
and was 2.0–2.2-fold greater than the non-origin contain-
ing sequence for the normal cells (Figure 7C). The low
abundance of DNA detected in the NRS immunopre-
cipitates indicated that the ChIP conditions were stringent
enough to prevent substantial non-speciﬁc association of
DNA with the immunoglobulins or agarose beads.
The results also indicated a 3–6-fold higher in vivo asso-
ciation of Fe65, REF-1, FKBP-25 and EEF1D in the
transformed cell lines compared to the normal ones, sug-
gesting a transformation-related increased association of
these proteins with the clone 3 origin. Use of the isogenic
pair of WI38 and WI38(SV40) ruled out the possibil-
ity that the observed increased binding of these
proteins in transformed cell lines might be due to cell
type.
DISCUSSION
Clones 3, 13 and 32 coincide with chromosomal
replication origins in both transformed and normal cells,
but support the autonomous replication of plasmids
solely in transformed cells
In this study, we took advantage of origin libraries that we
had generated previously, which contain clones with
autonomous replication activity that have been sequenced
and characterized (32). We focused on three of these
clones (3, 13 and 32) that had been found to replicate
autonomously only in transformed cells and examined
both their ectopic an in situ replication activity in trans-
formed and normal cells, by transient episomal replication
assays (Figure 1) and nascent strand abundance analysis
(Figure 3), respectively. Interestingly, all three clones were
able to support autonomous replication of their respective
plasmids after transfection into HeLa (transformed) cells
but not NSF (normal) cells, suggesting the presence
of a more favorable environment (factors) present in
transformed cells that is absent in normal ones, which
allows for transformation-speciﬁc ectopic replication.
Trans-acting factors are apparently responsible for the
transformation-speciﬁc episomal replication of the
clones, as the cis-acting sequences transfected into both
the transformed and normal cells were identical. The
presence of such factor(s) possibly alters the DNA
topology, facilitating episomal replication, as also sug-
gested in a recent study of DNA synthesis of extrachro-
mosomal DNA (41).
Origin activities in normal versus transformed cells
The above results suggested a transformation-speciﬁc rep-
lication and the existence of transformation-speciﬁc
origins. We thus examined the ability of the three clones
to act as chromosomal replication origins by in situ repli-
cation assays in two transformed and two normal cell
lines, using real-time PCR to quantify the abundance of
nascent DNA (Figure 3). All three clones at their respec-
tive chromosomal loci corresponded to replication origins
in both the transformed and normal cell lines tested, but
these origins were 2–3-fold more active in the transformed
cells compared to the normal ones at the chromosomal
loci of all three clones.
The replication origin associated with clone 3
exhibited the highest level of nascent DNA abundance
followed by clone 13 then clone 32. One possible expla-
nation is that the origin at clone 3 may be activated in
more cells per population by comparison to the origins
corresponding to clones 13 and 32. Alternatively, there
may be other initiation sites present in the vicinity of the
origins associated with clones 13 and 32, causing origin
interference (42), which may result in a broader and
ﬂatter peak by comparison to the origin associated
with clone 3, leading to their observed lower level of
nascent DNA abundance. Regarding the origin
associated with clone 13, which is present at two copies
per haploid genome at a level of 99% homology, it was
not possible to design primer sets to distinguish between
the two chromosomal locations due to the high
homology and thus it could not be determined whether
the origin activity stemmed from chromosome 1 or chro-
mosome 4 or both.
These results indicated that the deregulated increase in
replication initiation may be an early event in the stepwise
progression to cancer occurring at the transformation
stage, causing replication stress, which may lead to
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Figure 6. Veriﬁcation of the proteins in the complex identiﬁed by
EMSA and mass spectrometry. Western blot analysis performed on
(A) T (electroeluted excised cdc6 supershift bands from transformed
NEs) and N (electroeluted excised cdc6 supershift bands from normal
NEs) samples as well as (B) T (electroeluted excised cdc6 supershift
bands from transformed NEs) and C (electroeluted excised control
bands) samples after SDS-PAGE and transfer onto a PVDF
membrane to conﬁrm the composition of the transformation-speciﬁc
complex with the following antibodies: anti-cdc6, anti-EEF1D,
anti-Fe65, anti-FKBP-25, anti-ORC1, anti-ORC2, and anti-REF-1.
The protein complexes have been analyzed independently a total of 4
times and the experiments were performed from diﬀerent cell batches
giving the same result each time.
Nucleic Acids Research,2010, Vol.38, No. 7 2327DNA double-strand breaks and activation of the DNA
damage checkpoint, increased genomic instability, and
tumor progression (43–45).
The diﬀerential origin activities observed between
the transformed and normal cells might be due to some
origins being ﬁred more than once, but the repeated initi-
ations be subsequently aborted to prevent gene ampliﬁca-
tion. It has been speculated that the early events
of genomic instability in a cancer cell might entail
unregulated origin ﬁring, providing substrates for genetic
recombination and further ampliﬁcation (46).
Alternatively, the diﬀerential origin activities might be
due to the clone origins not always being used in normal
cells, but used in a higher percentage of
transformed cells. It is conceivable that in normal cells,
at least during some S phases, the DNA at the clone ori-
gins might be replicated by upstream or downstream
origins ﬂanking this region.
Figure 7. Comparative analysis of the expression, chromatin-bound levels as well as in vivo association of Fe65, REF-1, FKBP-25 and EEF1D to the
chromosomal locus of clone 3 in normal and transformed cell lines. (A) Expression levels and (B) Chromatin bound levels of Fe65, REF-1, FKBP-25
and EEF1D. Twenty and forty micrograms of whole-cell extracts or chromatin-enriched fractions were subjected to SDS-PAGE and transferred onto
a PVDF membrane and probed with anti-Fe65, anti-REF-1, anti-FKBP-25 and anti-EEF1D antibodies. Anti-actin was used as a loading control. (C)
Histogram plot of the quantiﬁcation by real-time PCR of immunoprecipitated DNA abundance (ng) at the chromosomal locus of clone 3 in two
transformed [HeLa and WI38(SV40)] and two normal (NSF and WI38) cell lines. Chromatin IP of the clone 3 chromosomal region was performed
with antibodies directed against Fe65 (dark gray bars), REF-1 (white bars), FKBP-25 (light gray bars) and EEF1D (spotted grey bars); normal
rabbit serum (NRS) (black bars) was used as a negative control. The clone 3 primer sets are described in the legend of Figure 3 and Supplementary
Table S2. The error bars represent the average of at least two experiments performed in triplicate and one standard deviation. (D) Western blot
analysis using anti-Fe65, anti-REF-1, anti-FKBP-25 and anti-EEF1D antibodies to verify the IP of Fe65, REF-1, FKBP-25 and EEF1D proteins in
all cell lines used. IP with NRS was used as a negative control.
2328 Nucleic Acids Research, 2010,Vol.38, No. 7In vivo association of ORC2, cdc6 and cdt1 at the clone
origins in normal versus transformed cells
Comparative analysis of the in vivo association of ORC2,
cdc6 and cdt1 with the chromosomal replication origins
corresponding to clones 3, 13, and 32 between two trans-
formed cell lines and two normal cell lines (Figure 4A–C)
showed that they were bound by these pre-RC proteins in
all cell lines. As expected from bona ﬁde replication
origins, the abundance of each pre-RC protein at any
given clone origin was enriched by at least 5.3-fold over
NRS and by at least 4.9-fold over any non-origin contain-
ing (negative control) region located at least 5kb away
from any origin. The highest level of association of
ORC2, cdc6 and cdt1 was at the clone 3 origin, the next
highest at the clone 13 origin and the lowest at the clone 32
origin, in agreement with their replication proﬁles.
Together, the nascent DNA and ChIP data indicate that
the chromosomal clone origins behave as such and are
bound by members of the pre-RC, as observed in other
well-characterized origins, such as those at the lamin B2
locus (47), c-myc locus (48) and b-globin locus (36).
Furthermore, the results revealed a 2–3-fold higher abun-
dance of these pre-RC proteins bound at all the clone
chromosomal origins of the transformed cells by compar-
ison to the normal ones, once more correlating with the
origin mapping results.
The diﬀerential association of ORC2, cdc6 and cdt1
observed between the transformed and normal cells is in
agreement with the ﬁnding that ORC2 is overexpressed
and bound at a higher frequency to chromatin in trans-
formed compared to normal cells (25) and that cdc6 as
well as cdt1 overexpression promotes malignant
behavior (49). The impact that these ﬁndings have on
pre-RC proteins playing a role during oncogenesis is
reviewed in (27), and have led to the suggestion that
there is a pre-RC checkpoint lacking in cancer cells (26).
The elevated binding of the pre-RC proteins to the clone
origins in transformed compared to normal cells may be
an event resulting from the deregulation of the pre-RC
checkpoint by two likely scenarios: origins ﬁring more
than once per cell cycle, due to an improper licensing of
these origins, leading to re-replication, causing genetic
instability and then cancer (28), or, alternatively, the dif-
ferential origin activities might be due to the clone origins
being activated at a lower frequency per cell cycle in
normal cells, but at a higher frequency in transformed
cells.
Transformation-speciﬁc DNA replication complexes
reveal possible new protein players involved in DNA
replication and cellular transformation
Comparative EMSA (Figure 5A) analysis of the ability
of NEs from transformed and normal cells to form
complexes on the origin sequence of clone 3 revealed the
formation of DNA–protein complexes 1 and 2 that were
not formed on the non-origin sequence. These complexes
were easily detectable in transformed NEs but barely
detectable in normal NEs. This was consistently
observed even after prolonged autoradiograph exposure
times (up to 14 days), suggesting that these complexes
exist in very low abundance and/or are highly unstable
in normal NEs (Figure 5A, B ii, C iii and iv).
Competitive EMSAs (Figure 5B i and ii) conﬁrmed that
these complexes were sequence-speciﬁc and supershift
EMSAs when using antibodies against known replication
initiation proteins (ORC1, ORC2 and cdc6) (Figure 5C i
and ii) conﬁrmed that complex 1 was indeed a DNA rep-
lication complex formed when using transformed NEs but
not when using normal NEs. (Figure 5C iii and iv).
MS analysis of the most prominent supershifted
complex that was produced by the anti-cdc6 antibody
revealed seven proteins that were present uniquely in the
transformation-speciﬁc DNA replication complex of
interest (Table 2): (i) Ku86, shown to be involved in
DNA replication (50) and references therein; (ii) DNA–
PKcs, which is the catalytic subunit of DNA–PK that
forms a complex with Ku70/Ku86 and has been
involved in DNA replication (51) and cellular transforma-
tion, as it has been found to modulate the stability of
c-Myc oncoprotein (52); (iii) Fe65, which has a role in
the response of cells to DNA damage (53) as well as inter-
acts with Tip60 (a histone acetyltransferase) (54); (iv)
REF-1, which is a multi-functional DNA repair enzyme
(55) and is elevated in human tumors (56); (v) U5
snRNP-speciﬁc 200-kDa protein, which was found in a
complex with Ku86 and DNA–PKcs as a transcriptional
activator (57) and may be involved in chromatin
remodeling through its interaction with N-CoR
deacetylase (58); (vi) FKBP-25, which may play a regula-
tory role in cell growth through its interaction with casein
kinase II complex (59) and also involved in chromatin
remodeling through its association with histone
deacetylases (HDAC1 and HDAC2) and the
HDAC-binding transcriptional regulator YY1 (60); and
(vii) eukaryotic translation elongation factor 1 delta
(EEF1D), which has been implicated in cellular transfor-
mation, as a higher level of EEF1D expression is
associated with a more invasive phenotype for breast
cancer cells (61) and poorer prognosis for esophageal car-
cinoma (62). In addition, a block of the translation of
EEF1D resulted in a signiﬁcant reversal of its oncogenic
potential (63). These proteins may represent new players
involved in DNA replication, as they seem to be involved
in overlapping processes such as response to DNA
damage and chromatin modiﬁcation, which may be
indirectly implicated in the process of cellular transforma-
tion. With the exception of Ku86 and DNA–PKcs, these
proteins have not been previously considered in the
context of DNA replication and their potential
involvement in this process in relation to cellular transfor-
mation requires further investigation. Thus far, in support
of this notion we know that several of these proteins have
a higher level of expression and chromatin association as
well as exhibit a  3–6-fold higher abundance in vivo at the
clone 3 origin in transformed compared to normal cells.
OVERALL SUMMARY AND CONCLUSION
Previous studies have suggested that there are at least two
types of changes in the activation of replication origins
Nucleic Acids Research,2010, Vol.38, No. 7 2329during cell transformation and malignancy: an increase in
origin activity at some loci (10–13) and the activation of
origins that are silent in normal cells (14,15). The origins
examined in this study fall under the category of those
whose activity is increased in tumor/transformed cells by
comparison to normal ones. Thus, it appears that there
are at least three subsets of origins: those that are normal
and remain unchanged, those with increased origin
activity in transformed/immortalized or malignant cells,
and those that are activated uniquely in tumor cells.
In summary, we have identiﬁed three clones that confer
autonomous replication of their respective plasmids in
transformed cells but not normal cells. These clones act
as chromosomal origins of DNA replication and are
bound by members of the pre-RC in both transformed
and normal cells, but they exhibit both diﬀerential origin
activity and pre-RC binding between transformed and
normal cells. Use of the most eﬃciently replicating clone
as bait to analyze protein–DNA complexes revealed a
transformation-speciﬁc DNA replication complex from
which we identiﬁed seven proteins that are overexpressed
as well as bound to chromatin at a higher level in trans-
formed compared to normal cells, in addition to being
associated  3–6-fold higher in vivo with the clone 3
origin in transformed compared to normal cells, indicating
that these proteins may be involved in the pathways
leading to deregulated DNA replication and cellular trans-
formation. The present data indicate that replication
origins (both active and cryptic) are used more frequently
in transformed cells than in normal ones. Although this
study did not identify any transformation-speciﬁc origins,
their existence cannot be ruled out. Experiments
addressing these possibilities as well as the role of the
proteins present in the transformation-speciﬁc complex
are ongoing.
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